$GALT News Article - Galectin Therapeutics Announces Positive Top-Line Results from a Phase 1b Clinical Trial Extension of Belapectin in Combination with KEYTRUDA in Advanced Metastatic Melanoma and Head and Neck Cancer
https://marketwirenews.com/news-releases/gale...45132.html